Christopher Y Chai - Net Worth and Insider Trading

Christopher Y Chai Net Worth

The estimated net worth of Christopher Y Chai is at least $684,442 dollars as of 2024-05-20. Christopher Y Chai is the CFO of Principia Biopharma Inc and owns about 6,841 shares of Principia Biopharma Inc (PRNB) stock worth over $684,442. Details can be seen in Christopher Y Chai's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Y Chai has not made any transactions after 2020-08-18 and currently still holds the listed stock(s).

Transaction Summary of Christopher Y Chai

Christopher Y Chai Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Y Chai owns 3 companies in total, including Principia Biopharma Inc (PRNB) , Surrozen Inc (SRZN) , and Consonance-HFW Acquisition Corp (CHFW.U) .

Click here to see the complete history of Christopher Y Chai’s form 4 insider trades.

Insider Ownership Summary of Christopher Y Chai

Ticker	Comapny	Transaction Date	Type of Owner
PRNB	Principia Biopharma Inc	2020-09-28	Chief Financial Officer
SRZN	Surrozen Inc	2021-08-11	director
CHFW.U	Consonance-HFW Acquisition Corp	2021-08-11	director

Christopher Y Chai Latest Holdings Summary

Christopher Y Chai currently owns a total of 1 stock. Christopher Y Chai owns 6,841 shares of Principia Biopharma Inc (PRNB) as of August 18, 2020, with a value of $684,442.

Latest Holdings of Christopher Y Chai

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PRNB	Principia Biopharma Inc	2020-08-18	6,841	100.05	684,442

Holding Weightings of Christopher Y Chai

Christopher Y Chai Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Y Chai has made a total of 3 transactions in Principia Biopharma Inc (PRNB) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Principia Biopharma Inc is the sale of 7,500 shares on August 18, 2020, which brought Christopher Y Chai around $745,275.

Insider Trading History of Christopher Y Chai

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Y Chai Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Y Chai Ownership Network

Ownership Network List of Christopher Y Chai

No Data

Ownership Network Relation of Christopher Y Chai

Christopher Y Chai Owned Company Details

What does Principia Biopharma Inc do?

Who are the key executives at Principia Biopharma Inc?

Christopher Y Chai is the Chief Financial Officer of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .

Principia Biopharma Inc (PRNB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Principia Biopharma Inc Insider Transactions

No Available Data

What does Surrozen Inc do?

Who are the key executives at Surrozen Inc?

Christopher Y Chai is the director of Surrozen Inc. Other key executives at Surrozen Inc include director & 10 percent owner Tim Kutzkey , 10 percent owner Column Group Iii Gp, Lp , and Exec. Vice President & Research Yang Li .

Surrozen Inc (SRZN) Insider Trades Summary

Over the past 18 months, Christopher Y Chai made no insider transaction in Surrozen Inc (SRZN). Other recent insider transactions involving Surrozen Inc (SRZN) include a net purchase of 387,096 shares made by Column Group Iii Gp, Lp , a net purchase of 387,096 shares made by Tim Kutzkey , and a net sale of 5,382,499 shares made by Blutt Mitchell J Md .

In summary, during the past 3 months, insiders sold 0 shares of Surrozen Inc (SRZN) in total and bought 774,192 shares, with a net purchase of 774,192 shares. During the past 18 months, 358,833 shares of Surrozen Inc (SRZN) were sold and 774,192 shares were bought by its insiders, resulting in a net purchase of 415,359 shares.

Surrozen Inc (SRZN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Surrozen Inc Insider Transactions

No Available Data

What does Consonance-HFW Acquisition Corp do?

Who are the key executives at Consonance-HFW Acquisition Corp?

Christopher Y Chai is the director of Consonance-HFW Acquisition Corp. Other key executives at Consonance-HFW Acquisition Corp include other: Former Director Christopher Haqq , Chief Scientific Officer Wen-chen Yeh , and other: Former VP Business Development House Joshua Cory .

Consonance-HFW Acquisition Corp (CHFW.U) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Consonance-HFW Acquisition Corp (CHFW.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Consonance-HFW Acquisition Corp (CHFW.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Consonance-HFW Acquisition Corp (CHFW.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

Consonance-HFW Acquisition Corp Insider Transactions

No Available Data

Christopher Y Chai Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Y Chai. You might contact Christopher Y Chai via mailing address: 2400 Bayshore Parkway, Suite 200, Mountain View Ca 94043.

Discussions on Christopher Y Chai

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.